Killer superbugs – the antibiotics-resistant bacteria will claim the whopping 10 million lives by 2050. The effect would be more catastrophic than cancer.
Superbugs will kill people in every 3 seconds in next four decades. It is a huge global fight, requiring multi-billion dollars.
Jim O’Neil, Britain’s Treasury secretary, revealed about the threat in a review on anti-microbial resistance. Since mid-2014 until today, one million people have died of drug-resistant infections.
According to BBC, the drug-resistant infections are more perilous than it was thought before. It is as destructive as terrorism.
Another problem is that antibiotics are being wasted while new ones are not being developed. Reducing the excessive use of antibiotic and analysing the drug resistance will help control the infections. Proper cleanliness and sanitation at public places will likewise cut off the health risks.
The review recommends a massive global campaign for people awareness about the risks. George Osborne, Britain’s chancellor, has called upon finance ministers from around the world to unite in this multibillion-dollar fight.
“Apart from the moral case for action, the economic cost of failing to act is too great to contemplate,” said Osborne in a report by The Advocate.
“So I am calling on other finance ministries to come together this year and, working with industry leaders and medical experts, agree on a common approach,” he added.
Lord O’Neill, an economist, said that Osborne is going to focus the issue with G7 and G20 finance ministers.
“We need that… We need to take it out of the health world and into the finance and business worlds,” said O’Neill in The Sydney Morning Herald.
He also criticised the use of antibiotics to boost the growth of animals, rather than curing their infections. In the USA alone, round 70 percent antibiotics are set for animal use only. He also added his anger over the unnecessary prescription of antibiotics to patients.
“I find it incredible that doctors must still prescribe antibiotics based only on their immediate assessment of a patient’s symptoms, just like they used to when antibiotics first entered common use in the 1950s,” said O’Neill.